Cambricon
688256
Foxconn Industrial Internet
601138
China Vanke Co.,Ltd.
000002
4
Kweichow Moutai
600519
5
Contemporary Amperex Technology
300750
CN Stock MarketDetailed Quotes
300676 BGI Genomics
- 38.55
- +0.41+1.07%
Noon Break Jan 23 11:30 CST
16.03BMarket Cap-157.99P/E (TTM)
39.03High38.31Low15.20KlotVolume38.64Open38.14Pre Close58.86MTurnover0.37%Turnover Ratio172.87P/E (Static)415.82MShares56.8952wk High1.63P/B15.90BFloat Cap32.9052wk Low45.77Limit Up412.52MShs Float259.49Historical High30.51Limit Down1.89%Amplitude13.87Historical Low0.10Dividend TTM38.73Avg Price6.58KlotAsk0.26%Div YieldTTM100Lot Size7.82KlotBid
BGI Genomics Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -26.11%3.78B | -11.09%4.47B | -16.29%4.46B | -8.28%4.73B | -14.12%5.11B | -21.04%5.02B | -12.27%5.33B | -21.71%5.16B | -15.39%5.96B | 0.93%6.36B |
| Transactional financial assets | 116.17%933.15M | -39.64%475.85M | -14.28%796.53M | -38.83%753.58M | -59.45%431.68M | -21.22%788.32M | -32.25%929.27M | -39.88%1.23B | -9.82%1.06B | -5.30%1B |
| Notes receivable and accounts receivable | 19.77%1.84B | 9.13%1.74B | 0.42%1.57B | -34.34%1.46B | 6.06%1.54B | 20.92%1.6B | 20.49%1.56B | 81.18%2.22B | -5.25%1.45B | -34.49%1.32B |
| -Notes receivable | 16.85%13.14M | 96.16%6.57M | 21.50%6.44M | 145.02%12.48M | 61.64%11.25M | -32.48%3.35M | -41.89%5.3M | -45.67%5.09M | -38.44%6.96M | 50.97%4.96M |
| -Accounts receivable | 19.79%1.83B | 8.94%1.73B | 0.35%1.56B | -34.75%1.44B | 5.80%1.53B | 21.12%1.59B | 20.93%1.56B | 82.16%2.21B | -5.01%1.44B | -34.63%1.31B |
| Other receivables (including interest and dividends) | -44.15%49.05M | -41.72%54.84M | -11.07%56.62M | -68.92%54.22M | 16.36%87.83M | 18.86%94.09M | -3.72%63.67M | 250.74%174.47M | -43.62%75.48M | -49.23%79.16M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --89.33M | ---- | ---- |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 630.16%9.16M | --11.83M |
| -Other receivable | ---- | -41.72%54.84M | ---- | ---- | ---- | 39.74%94.09M | ---- | 71.17%85.14M | ---- | -56.82%67.34M |
| Advance payment | -36.37%38.17M | -45.53%48.66M | -56.64%45.04M | -58.74%33.73M | -59.04%59.99M | -29.76%89.34M | -43.65%103.89M | 2.51%81.75M | -11.60%146.46M | -16.05%127.2M |
| Inventories | 16.24%715.34M | 0.52%604.19M | -17.07%593.45M | -16.11%602.18M | -50.59%615.4M | -40.85%601.05M | -31.36%715.6M | -18.22%717.83M | 18.33%1.25B | 3.16%1.02B |
| Receivable financing | 149.63%15.33M | 85.67%12.02M | 20.52%4.73M | 61.17%7.24M | -23.95%6.14M | -74.99%6.47M | -80.74%3.92M | -77.48%4.49M | -33.62%8.07M | 108.06%25.88M |
| Non-current assets due within one year | ---- | --43.37M | --57.77M | 415.61%57.77M | ---- | ---- | ---- | --11.2M | ---- | ---- |
| Other current assets | 1.51%199.39M | 27.38%233.04M | 10.43%259.42M | 34.07%235.27M | 32.59%196.41M | 36.62%182.95M | 58.33%234.92M | 21.85%175.48M | 22.70%148.13M | 22.06%133.91M |
| Total current assets | -5.94%7.57B | -8.37%7.68B | -12.29%7.85B | -18.85%7.93B | -20.25%8.05B | -16.72%8.38B | -12.36%8.95B | -11.42%9.78B | -10.16%10.09B | -6.71%10.07B |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.91%11.1M | 3.95%10.99M |
| Other equity investment | -37.18%220.09M | -39.95%214.62M | -34.60%221.3M | -33.90%223.7M | 46.52%350.36M | 52.37%357.38M | 40.20%338.4M | 40.21%338.44M | -10.58%239.13M | -11.69%234.55M |
| Other non-current financial assets | -4.90%641.06M | -3.69%651.43M | -4.41%663.16M | -0.54%669.5M | 9.33%674.08M | 39.13%676.36M | 47.28%693.78M | 48.37%673.11M | 45.75%616.56M | 22.87%486.15M |
| Long-term equity investment | -4.70%329.63M | 18.82%350.27M | 7.49%353.9M | 13.34%359.06M | 44.93%345.89M | 26.76%294.78M | 70.82%329.23M | 64.69%316.81M | 77.55%238.67M | 78.86%232.55M |
| Long term receivable account | -12.49%12.94M | -30.91%13.6M | -19.79%14.73M | -21.19%14.53M | -37.44%14.79M | -10.21%19.69M | -73.53%18.36M | -71.97%18.44M | -63.98%23.64M | -65.81%21.93M |
| Fixed assets | ---- | 109.31%2.63B | ---- | ---- | ---- | -1.28%1.26B | ---- | 6.37%1.24B | ---- | 17.86%1.27B |
| Constru in process | ---- | -64.76%472.48M | ---- | ---- | ---- | 1,806.61%1.34B | ---- | 1,854.21%752.33M | ---- | 8.88%70.33M |
| Intangible assets | 4.98%418.05M | 7.03%422.45M | 7.62%427.54M | 1.93%418.82M | 8.00%398.2M | 66.66%394.69M | 67.03%397.28M | 67.40%410.89M | 68.02%368.71M | 15.19%236.82M |
| Development expenditure | 25.95%181.67M | 23.85%169.09M | 24.45%155.67M | 36.47%161.12M | 57.07%144.24M | 67.59%136.52M | 47.62%125.09M | 51.84%118.06M | 71.39%91.83M | 94.26%81.46M |
| Goodwill | 0.00%47.11M | 0.00%47.11M | 0.00%47.11M | 0.00%47.11M | 0.00%47.11M | 0.00%47.11M | 0.00%47.11M | 0.00%47.11M | 0.00%47.11M | 0.00%47.11M |
| Long deferred expense | 83.73%175.3M | 84.22%187.7M | 100.50%184.37M | 120.60%201.74M | -2.03%95.41M | -0.62%101.89M | -2.64%91.95M | -8.46%91.45M | 21.60%97.39M | 82.79%102.52M |
| Deferred tax assets | 16.02%289.08M | 7.12%262.73M | 4.89%258.15M | 2.24%241.58M | 3.51%249.17M | 7.21%245.27M | 21.20%246.12M | 17.98%236.29M | 35.29%240.72M | 17.85%228.77M |
| Usufruct assets | -41.35%80.44M | -44.44%94.04M | -43.21%108.22M | -38.87%120.33M | -25.16%137.15M | -0.13%169.26M | 9.53%190.55M | 1.40%196.82M | -16.27%183.25M | -27.60%169.48M |
| Other non current assets | 11.51%203.67M | 0.20%180.87M | -29.44%145.32M | -9.58%152.64M | 1.90%182.64M | -7.82%180.51M | 18.24%205.95M | -8.79%168.82M | 0.23%179.23M | 14.49%195.83M |
| Total non current assets | 5.53%5.71B | 9.14%5.7B | 18.69%5.61B | 23.22%5.68B | 42.92%5.41B | 53.92%5.22B | 46.95%4.73B | 43.20%4.61B | 25.56%3.79B | 14.56%3.39B |
| Total assets | -1.33%13.28B | -1.65%13.38B | -1.59%13.46B | -5.37%13.61B | -3.02%13.46B | 1.09%13.61B | 1.85%13.67B | 0.92%14.39B | -2.60%13.88B | -2.13%13.46B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | --2.36M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -80.00%5.01M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | -92.52%325.94K | ---- | ---- | 3,492.05%471.03K | 11.63%4.36M |
| Notes payable and accounts payable | 46.43%1.08B | -6.67%959.17M | -4.33%760.29M | -15.64%864.6M | -18.46%735.24M | 43.57%1.03B | 87.88%794.68M | 27.26%1.02B | 6.73%901.64M | -16.27%715.86M |
| -Notes payable | 94.53%169.51M | 62.69%107.18M | 8.99%80.3M | -94.52%14.41M | -46.51%87.14M | -11.54%65.88M | --73.68M | -23.84%263.19M | -56.60%162.92M | 28.20%74.47M |
| -Accounts payable | 39.96%907.11M | -11.43%851.99M | -5.69%679.99M | 11.62%850.18M | -12.27%648.1M | 49.97%961.9M | 70.46%720.99M | 65.67%761.68M | 57.37%738.71M | -19.51%641.38M |
| Contract liabilities | -9.87%598.45M | -7.67%625.77M | -16.55%659.24M | -24.71%699.71M | -30.65%664.01M | -30.09%677.76M | -28.55%789.97M | -34.07%929.35M | -30.93%957.52M | -5.79%969.47M |
| Salaries payable | -90.06%11.21M | -32.20%40.01M | -47.52%40.43M | -38.85%138.78M | -30.54%112.76M | -64.32%59M | -40.18%77.03M | 1.57%226.95M | 949.39%162.35M | 78.91%165.37M |
| Taxs payable | -49.98%56.54M | -29.50%67.17M | -10.48%96.85M | -30.72%86.82M | -29.02%113.03M | -37.17%95.28M | -36.91%108.19M | -46.30%125.31M | -54.84%159.24M | -50.51%151.63M |
| Other payable (including interest and dividends) | 13.71%682.36M | 12.44%654.78M | -1.74%672.25M | -17.83%665.4M | 4.88%600.08M | 6.01%582.36M | 19.38%684.13M | 51.01%809.74M | -9.41%572.16M | -15.83%549.35M |
| -Dividend payable | ---- | ---- | --3.18M | --3.18M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 12.44%654.78M | ---- | ---- | ---- | 6.01%582.36M | ---- | 51.01%809.74M | ---- | -15.83%549.35M |
| Non current liabilities due within one year | -45.53%426.56M | -43.91%430.85M | 3.81%829.16M | 0.43%812.98M | 387.35%783.14M | 349.88%768.1M | 5.51%798.7M | 444.18%809.54M | 13.20%160.69M | 24.75%170.73M |
| Other current liabilities | -13.42%24.74M | -13.38%25.7M | 2.32%26.49M | -4.28%28.76M | -0.27%28.58M | 1.65%29.68M | -5.03%25.89M | 37.62%30.05M | 125.42%28.66M | 87.23%29.19M |
| Total current liabilities | -5.28%2.88B | -13.41%2.81B | -5.91%3.08B | -16.65%3.3B | 3.20%3.04B | 17.36%3.24B | 2.56%3.28B | 16.91%3.96B | -13.59%2.94B | -11.42%2.76B |
| Current liabilities | ||||||||||
| Long term loan | 66.47%347.54M | 131.92%306.18M | --242.08M | --215.68M | --208.77M | --132.02M | ---- | ---- | ---- | ---- |
| Long term account payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 10.41%710.82M |
| Deferred tax liabilities | -19.74%21.49M | -66.05%12.58M | -66.05%10.84M | -74.54%13.13M | 400.19%26.78M | 969.57%37.05M | 372.99%31.91M | 893.25%51.56M | -52.32%5.35M | -38.68%3.46M |
| Long term deferred income | -1.67%14.19M | 0.48%15.05M | -0.74%16.99M | -21.76%15.39M | -38.52%14.43M | -47.16%14.98M | -51.07%17.12M | -45.46%19.68M | -45.48%23.47M | -30.75%28.34M |
| Lease liabilities | -36.36%53.38M | -51.03%56.37M | -51.35%58.92M | -50.43%67.75M | -15.28%83.89M | 50.40%115.11M | 66.51%121.11M | 61.86%136.68M | -2.56%99.02M | -36.01%76.54M |
| Total non current liabilities | 30.77%436.61M | 30.43%390.18M | 93.26%328.82M | 50.03%311.95M | -60.97%333.87M | -63.48%299.16M | -78.77%170.14M | -85.45%207.92M | -41.79%855.47M | -43.99%819.16M |
| Total liabilities | -1.71%3.31B | -9.70%3.2B | -1.02%3.41B | -13.32%3.61B | -11.26%3.37B | -1.14%3.54B | -13.75%3.45B | -13.49%4.16B | -22.09%3.8B | -21.82%3.58B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.46%415.82M | 0.46%415.82M | 0.00%413.91M | 0.00%413.91M | 0.00%413.91M | 0.00%413.91M | 0.00%413.91M | 0.00%413.91M | 0.00%413.91M | 0.00%413.91M |
| Capital reserve funds | 3.90%4.74B | 4.42%4.72B | 3.15%4.63B | -1.89%4.59B | -2.58%4.56B | -3.40%4.52B | -3.88%4.49B | 0.49%4.68B | 0.89%4.68B | 1.01%4.68B |
| Surplus reserve funds | 0.00%207.97M | 0.00%207.97M | 0.00%207.97M | 0.00%207.97M | 22.99%207.97M | 22.99%207.97M | 22.99%207.97M | 22.99%207.97M | -2.83%169.09M | 2.91%169.09M |
| Retained profit | -3.12%4.45B | 1.24%4.64B | -7.07%4.63B | -6.50%4.62B | -6.65%4.6B | -7.01%4.58B | 7.18%4.98B | 14.36%4.94B | 15.36%4.92B | 20.37%4.92B |
| Less:Treasury stock | -13.36%99.92M | -13.36%99.92M | 0.00%115.32M | -65.75%115.32M | -72.84%115.32M | -72.84%115.32M | -72.84%115.32M | 282.90%336.75M | 141.45%424.69M | 141.45%424.69M |
| Other composite income | -59.99%114.27M | -49.51%158.25M | 28.90%132.01M | -16.80%143.11M | 47.85%285.61M | 3,261.49%313.41M | 158.62%102.41M | 212.74%172M | 402.78%193.18M | 85.51%-9.91M |
| Shareholders equity without minority interests | -1.20%9.83B | 1.20%10.04B | -1.80%9.9B | -2.15%9.86B | -0.07%9.95B | 1.71%9.92B | 8.36%10.08B | 8.13%10.08B | 7.56%9.95B | 7.66%9.75B |
| Minority interests | -1.47%143.48M | 0.01%145.98M | -0.15%143.52M | -0.21%144.78M | 12.24%145.63M | 15.89%145.96M | 15.91%143.73M | 18.09%145.09M | 5.36%129.75M | 10.17%125.95M |
| Total shareholder equity | -1.20%9.97B | 1.18%10.19B | -1.78%10.04B | -2.13%10B | 0.09%10.09B | 1.89%10.07B | 8.46%10.23B | 8.26%10.22B | 7.53%10.08B | 7.70%9.88B |
| Total liabilityies and equity | -1.33%13.28B | -1.65%13.38B | -1.59%13.46B | -5.37%13.61B | -3.02%13.46B | 1.09%13.61B | 1.85%13.67B | 0.92%14.39B | -2.60%13.88B | -2.13%13.46B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.